BioLife Solutions, Inc. (BLFS)

NASDAQ • Healthcare

$37.29

+$0.51 (+1.4%)

Market closed

Last close at October 2, 2026 at 20:00 UTC

Open$37.02

Day Range$36.83 - $37.98

Avg. Volume (3M)1M

Market Cap$1.8B

P/E Ratio36.2

52 Week Range

$17.86$39.76

Next EarningsIn 32 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$28.4M100%

Gross Profitminus cost of goods$18.2M64%

Operating Incomeminus R&D and overhead$1.6M6%

Net Incomeminus taxes and the rest$45.1M158%

Fundamentals & Financials

Revenue (TTM)

$102.8M

Net Income (TTM)

$50.4M

EPS (TTM)

$1.03

ROA (TTM)

11.27%

Current Ratio

9.69

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-1550.0%Q3 2025-$0.33

+1900.0%Q4 2025$0.04

+300.0%Q1 2026$0.04

+300.0%Q2 2026$0.04

+2812.0%Q3 2026$0.91

Nov 5

in 32 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +2812.0%

BioLife Solutions beat both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 6, 2026, as revenue rose about 12% to roughly $28.5 million and EPS of $0.04 topped the $0.03 estimate by about 47%; the per-share result also improved from -$0.33 a year ago. Revenue also edged the $27.8 million consensus by roughly 2%, while gross profit came in at about $18.3 million with gross margin near 64%. Operating cash flow was about $5.9 million. Consensus for the next period calls for EPS of $0.01 on revenue of $29.0 million.

View full earnings history

About BioLife Solutions, Inc.

BioLife Solutions, Inc. (NASDAQ: BLFS) develops and sells tools used in biopreservation and handling for the healthcare field, particularly cell and gene therapy workflows. Across media, thawing devices, shipping systems, freezer equipment, and storage services, it generated $96.2 million of revenue in FY2025.

Name

BioLife Solutions, Inc.

CEO

Roderick de Greef

Website

www.biolifesolutions.com

Industry

Healthcare

Year Founded

1987

Employees

155

Today's Snapshot

AI-generated

BLFS closed 1.4% above yesterday's close, while its sector was flat. Volume was roughly three times its usual level.

Trading Volume

Above 10d avg 1.1M

2.8M

vs S&P 500 Today

Outperforming Market

+0.63%

Updated: October 2, 2026 at 20:21 UTC

Technical Indicators

4 Buy3 Neutral1 Sell

BLFS exhibits a bullish technical posture with price above most medium- and long-term moving averages, supported by a strong ADX that points to a well-established trend. Momentum is constructive—RSI around the mid-50s and positive short-term momentum—while MACD is mildly positive, and OBV shows healthy accumulation. Short-term averages sit near the price, keeping near-term signals mixed, and volatility is moderate with an ATR near $1.1. Classic pivot sits close to the market and does not contradict the uptrend. Technical takeaway: Buy (overall score 0.42).

All signals